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In this study, lanolin alcohol as well as lanolin 
alcohol-povidone films (1:1 . 5) were investigated as a poten-
tial drug delivery system. The in vitro drug release from 
these films was studied in terms of the effect of agitation, 
film thickness and drug concentration. 
The rate of release of Cortisol from lanolin alcohol 
films was not affected by the intensity of agitation. More-
over, the film matrix was found to remain essentially in-
tact throughout the release process. Further analysis of 
the data revealed that Higuchi's diffusion-controlled 
granular matrix model explained the mechanism of Cortisol 
release from such films. 
The results of drug release from lanolin alcohol-
povidone films have shown that although Higuchi's release 
rate constant was found to be independent of film thick-
ness, it was affected by the intensity of agitation, since 
the rate constant was found to increase as agitation speed 
was increased, especially at low speeds. In addition, povidone 
was found to leach out of the film matrix along with the drug. 
These factors, in conjunction with further analysis of the 
drug, explained the failure of this film system to conform 
to the matrix-controlled diffusion model. The release 
rate of Cortisol from this film system was foun d to follow 
first-order dependence o n drug concentration. 
The drug was found to be completely insoluble in 
lanolin alcohol, and slightly soluble in povidone . Povidone 
was found to enhance the solubility of Cortisol in water. 
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The us e of drugs incorpor ated into an inert mat r ix to 
achieve controlled release has been unde r extensive research 
fo r the past few decades . Minimization of patient complianc e 
probl ems through the use of pro l o nged actio n dosage forms is 
o ne of the ma j o r factors r esponsible fo r this interest. 
Another fac tor that has sparked interest in cont ro ll ed 
de livery systems has b een the r ap id gr owth of polymer tech-
no logy a nd its app~i cation to the solution of many biomedical 
probl ems . Many advantages can be obta ined by t h e use of such 
controlled systems. Fo r instance, it makes it possible to 
decrease the f reque ncy with whi c h the patien t has to t ake 
the dos age, a nd to prolong the act ivi ty throughout the n ight 
so the patie nt is not dis turbed during hi s s l eep . Furth er-
more, fewer side effect s could occur, when a constant blood 
level of the drug is maintained over a desir e d period of 
time. Numer o us medical applicat i o n s of such systems have 
been r e porte d in dermatologic prac ti ce (1,2) , optha l mic 
practice (3), vaginal d ev i ces (4 - 6), and long ter m buccal 
absorption of drugs (7). 
A major function of the skin is the r etardat i on of t he 
diffusion and evapo ration of wa t e r from within the body, 
except at the sweat glands. The stratum corn e um is probably 
r e sponsibl e for this ret a rdatio n. Drugs may be applied to 
1 
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the skin for a local effect, especially on the superficial 
layers of the epidermis. The drugs are incorporated into 
vehicles which adhere to the skin, allowing diffusion of 
drug molecules out of the vehicle into the epidermis. 
Hydration of the stratum corneum is probably the most im-
portant factor in enhancing the rate of skin penetration. 
The prevention of water loss by the application of occlusive 
plastic film in steroid treatment of different skin diseases 
leads to accumulation of larger amounts of water in the 
skin layer, and the subsequent enhancement of the applied 
steroid penetration (8-10). McKenzie and Stoughton (9) 
have increased the percutaneous absorption of cortico-
steroids by the occlusion of the skin surface with Saran 
Wrap® . The occlusion of the skin surface has resulted in 
a 100-fold difference in the absorption over simple topical 
application. Vehicles also play an important role in per-
cutaneous absorption of several drugs. Poulsen et al. (11) 
have investigated the release of fluocinolone acetonide and 
its acetate ester from gelled propylene glycol-water vehicles . 
It was found that steroid release is a function of its 
concentration, solubility in the vehicles, and the partition 
coefficient between the vehicles and the receptor phase. 
Katz et al. (12), have observed that the structural changes 
which produce potent topical anti-inflammatory cortico-
steroids provided the physical properties necessary to achieve 
effective percutaneous absorption, and effective biological 
3 
activity . Coldman et al. (13) have enhanced the skin penetra-
tion of fluocinolide and fluocinolone acetonide from vehicles 
containing different proportions of isopropanol and propylene 
glycol. The incorporation of dimethylsulfoxide (14) and 
more recently, Azone -~15) into the dermatologic preparations 
have also been successfully shown to enhance drug penetra-
tion across the stratum corneum. Wester et al. (16) have 
noticed in the in vitro study in the Rhesus monkey that the 
level of absorption of hydrocortisone is significantly in-
creased during long-term administration. 
The use of polymers in controlled drug delivery systems 
has been the focus of interest in many pharmaceutical research 
laboratories. Sciarra and Gidwani (1,2) have shown that 
the nature of the films and their physical properties had a 
significant effect on the release of drugs,and on the applica-
tion of such films as aerosol sprays. Loucas and Haddad (3) 
observed that by the use of ophthalmic flakes of pilocarpine 
alginate as a solid dosage form, the availability of pilocar-
pine in the cul-de-sac of albino rabbit's eyes, may be more 
uniform as a consequence of diminished diffusion through the 
gel matrix, in contrast to liquid dosage forms where the dose 
is immediately released into the conjunctival fluids . Chien 
et al., have taken advantage of the high permeability of 
silicone polymers to steroids in the development of vaginal 
devices in the shape of rings. The factors influencing the 
rate of release of ethynodiol diacetate from solid silicone 
4 
polymer vaginal devices were evaluated (4). Two types of 
release mechanisms, matrix- controlled and partition- controlled, 
were noticed when the release profiles of ethynodiol diacetate 
from these vaginal devices were followed daily in these 
systems (5) . The solution- solubility dependency of the con-
trolled release of the drug from such matrices was mathe-
matically analyzed (6). Roseman and Higuchi (17) have 
studied the release of medroxyprogestrone acetate from a 
silicone rubber matrix in vitro. This study has suggested 
that the partition coefficient, diffusion coefficient, drug 
concentration within the polymer, and agitation conditions 
play important roles in the release process . In another 
study (18), Roseman found that the amount of four progesterone-
type steroids, released from the same silicone matrix sys-
tem was dependent upon the molecular structure of the 
steroid. Borodkin and Tucker (19) used an additive polymer, 
hydroxypropylcellulose, which was selected on the basis of 
hydrophillic properties to increase the rate of release of 
methyapyrilene hydrochloride, sodium pentobarbital, and 
salicylic acid dispersed in films composed of different 
ratios of hydroxypropylcellulose and polyvinyl acetate . The 
effect of a leachable component, polyethylene glycol, on ethyl 
cellulose films has been investigated (20). Luongo et al. 
(21) have attempted to formulate a topical spray-on 
bandage as an effective preparation for contaminated wounds . 
The results indicated that neomycin sulfate and triclosan 
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were released from ethylcellulose-polyamide resins films, and 
the spray-on bandages did reduce the degree of infection 
about the wound. Shaw et al. (22) have developed a trans-
dermal therapeutic system for scopolamine. These systems were 
designed to deliver · the drug at various rates to the skin 
surface, and hence to the systemic circulation. The different 
rates of scopolamine permeation through the skin were evaluated 
for their ability to prevent nausea and vomiting due to 
motion. 
Lanolin alcohol*, a non-polymeric material, has been 
under investigation in our laboratories (23,24). It was 
observed that lanolin alcohol forms films which could be 
easily isolated from mercury substrate. The film-forming 
potential of lanolin alcohol was evaluated. The film 
characteristics were improved by the inclusion of ethyl 
cellulose. Triamcinolone acetonide was used as a model 
drug. The release kinetics from such a film system were 
reinvestigated and confirmed (25). The use of non-polymeric 
substances, such as lanolin alcohol, as film formers has 
many advantages: 
a) they could be designed to provide sustained 
drug delivery. 
b) hazards associated with monomeric impurities in 
polymer systems could be avoided. 
*Mixture of aliphatic alcohols, triterpenoid alcohols, 
and sterols, obtained by hydrolysis of lanolin. 
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c) films of these materials are easily washable from 
the skin without leaving any traces. 
d) non-polymeric materials are easy to manipulate and 
formulate. 
Because of its favorable physico-chemical properties and 
high degree of physiological tolerance, polyvinylpyrrolidone 
(PVP) is used for many different purposes in pharmacy and 
medicine. Both types of PVP, soluble and insoluble, are 
used in the pharmaceutical industry as film formers, tablet 
binders, thickeners, so lubilizers, and tablet disintegrants. 
Dakkuri et al . (26), have utili zed PVP as a channeling agent 
by its incorporation into a mixture of carnauba wax and 
stearyl alcohol by fusion and subsequent congealing. The 
results indicated that fusion is essential for channel forma-
tion . The addition of certain substances, ethyl cellulose and 
shellac, was found to e liminate the tackiness associated with 
PVP films due to the hygroscopicity of PVP (27). 
Research background: 
The continuing investigation about the potential of lano-
lin alcohol as a film-former has resulted in the development 
of a new film system of PVP-lanolin alcohol (28 ). Series of 
films of PVP andjor lanolin alcohol and Cortisol, a topical 
anti-inflammatory agent, as a model drug were prepared. It 
was observed that as the proportion of lanolin alcohol was 
increased in the films, they became translucent, flexible, 
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and could be more easily isolated. It was also noticed that 
both sward hardness and modulus of elasticity were sig-
nificantly decreased by the increase in the proportion of 
lanolin alcohol. The wettability of PVP films was decreased 
by the incorporation of small amounts of lanolin alcohol, re-
sulting in higher contact angles due to the hydrophobicity 
of lanolin alcohol. It was found that the rate of Cortisol 
release was markedly decreased with decreasing PVP content 
and increasing lanolin alcohol in the films. This work is 
a continuing research o n the same system, PVP-lanolin 
alcohol films, to further investigate the mechanism by 
which Cortisol is released from such a film matrix. Two 
film composit ions film #6 (film A), a nd film #9 (film B), 
have been c hose n fro m the above-mentioned work to study 
the effect of different factors on drug r e l ease (Table I). 
Th e di ffusion of the drug from the film vehicle into 
the aqueous release me dium in vitro has been studied . The 
concentration gradient occurs in the appli e d phase a nd the 
aqueous receptor fluid assumed to be a perfect sink since 
drug concentration attained at any given time was never 
more than 7.7% of the r e po rted drug solubility (29) at 
37°C. 
According to the results of a theoretical analysis of the 
mathematical relations hips concerning the rate o f release 
of solid drugs dispersed in solid matrices, two mechanisms 
of drug release have been developed by Higuchi (30): 
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(I) Unidirec tional drug r e l ease from a planar homo-
geneous matrix. 
(II) Unidirectional drug release from a p lanar granular 
matrix. 
(I) Unidirec tional drug r elease fr om a plana r homo geneous 
matrix: 
In this mechani s m, the drug is presumed to diffuse through 
and fro m the uniform homo geneous matrix, and out into the 
perfect sink which i s the b at hing solvent. The amount of 
drug released from such a system into the b athin g me dium 
would be determined by the following relationship: 
Where: 
Q =~Dt (2A - C ) C s s . ( Eq. 1) 
Q is the a mount of drug released after time t per unit 
exposed area . 
D i s the diffusivi ty of the drug in the ho mogeneous 
matrix me di a . 
A i s the t o t a l amoun·t of drug present in t h e rna trix 
per unit volume . 
Cs i s the solubility of the drug in the matrix sub-
stance. 
(II) Unidirectiona l drug r e l ease from a plan a r gr a nul a r matrix: 
Th e drug i s leached o u t f r om this matrix by t h e bathing 
fluid, whic h is abl e to go into the drug-matrix phase through 
pores, c r acks , and intergranular spaces. By the s l ow dissolution 
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of the drug into the permeating fluid, the drug is assumed 
to diffuse through the channels and cracks. Higuchi's · model 
(Eq. 1) has been modified for the effective volume where 
diffusion can occur and t h e effective diffusional path 
the following relationship has resulted: 
Q =J~E (2A - . . . ( Eq. 2) 
Where: 
Q is the amount of drug released after time t per unit 
exposed area . 
D is the diffusivity of the drug into the permeating 
f luid. 
T is the tortuosity of the capillary system. 
A is the total amount of drug present in the matrix 
per unit volume. 
Cs is the solubility of the drug in the permeating 
fluid. 
E is the porosity of the matrix. 
The derivation of both equations 1 and 2 (31) is based 
on the existence of a pseudo- steady state condition during 
the release process. It is also ass umed that the drug 
particles are very small relative to the average distance 
of diffusion and are uniforml y distributed in the matri x . 
I t was also stated that these equations would be essentially 
valid for systems in which A is greater than C and C by 
S E S 
a factor of three or four. 
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Both equations describe drug r elease as being linear 
with square root of time: 
( Eq. 3) 
Where K is the release rate constant 
KH =,JD (2A - Cs) c s Homo geneous matrix (Eq. 4) 
KG Jr· ( 2A - ECS) c Granular matrix . (Eq. 5) s 
In this study the release of Cortisol was examined to 
determine whether or not it obeys one of the Higuchi models. 
EXPERIMENTAL 
Materials: 
1. Lanolin Alcohol (Super Hartolan, Croda Inc., 
New York, New York (Lot #72577). 
2. Polyvinylpyrrolidone, Povidone R , K-30 (PVP) 
Matheson, Coleman & Bell, Manufacturing Chemists, 
Nortwood, Ohio. 
3. Hydrocortisone (Cortisol R ), Amend Drug & Chemical 
Co., Inc., Irvington, New Jersey ( Lot #F16755 G08). 
4. Isopropyl Alcohol, U.S.P. (2-Propanol), J. T. 




Ethyl Acetate "Baker Analyzed" , J . T. Bake r 
Chemical Co., Phillipsburg, New Jersey (Lot 
#0 19002494) . 
Preparation of the Solution: 
A solution containing the appropriate amounts of Povidone, 
Lanolin Alcohol and Cortisol (Table I) was prepared. The 
required quantities of the drug and film formers were dis-
solved in about 40 ml of isopropanol by gently heating i t in 
a water bath at 50°C. The solutions were checked by visual 
11 
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examination, to ensure the absence of any suspended particles. 
The solutions were cooled to room temperature and then com-
pletely transferred into a 50-ml volumetri c f lask, with the 
aid of two washings. The volume was then adjusted to the 
mark. 
Preparation of the Films: 
All films were cast from a 10% (w/v) solution which con-
tained the drug and film formers. Five ml of the solution 
was poured into aluminum petri dishes (Surface area 44.18 
cm
2
) using a PipetmanGY pipette. 1 The dishes were kept on 
a level surface to ensure the uniform distribution of the 
solution, and films of even thickness. The dishes were par-
tially covered to allow uniform evaporation of the solvent 
at room temperature. The solution was left to evaporate 
over 48 hours. The complete dryness of the films was con-
firmed by weighing the dishes to a constant weight. The 
film-coated petri dishes were stored in a desiccator con-
taining anhydrous Calcium Sulphate, for about 24 hours prior 
to the release studies. The unidirectional release of 
Cortisol from the films was ensured by checking fo r the 
adherence of the film to the dish bottom throughout the 
release process. 
1 Pipetman ® , Model p-5000D, Woburn, Massachusetts. 
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Drug Release St udies: 
The release studi es were carried out using a dissolution 
assembly
2 
(Figure 1), with the following modifications: 
a) t h e flas k s were replaced by 1000- ml bottomed 
polypropylene beakers. 
b) the dissolution basket assemblies were replaced by 
stainless steel stirrers with a propeller of 4 . 5 
e m diameter. 
Three hundred ml of distilled water previously equili-
brated at 37°C were added to each beaker, followed by the 
careful immersion of aluminum dishes with a test film adhered 
to the bottom. The agitation speed was maintained at 30 
rpm throughout each experiment and the water bath t empe ra-
a ture was kept at 37~0.5 C. The effect of the agitation speed 
on the release was studied at the stirring rates of 0, 10, 
30, 60, 90, 150, and 210 rpm. Three ml of the sample we re 
withdrawn at appropriate time inte rvals over 24 hours, and 
analyzed for Cortisol content . Each sample (3 ml) was re-
placed by an equal volurr.e of distilled water in order to 
keep the total volume constant . A c umul at i ve correction 
was made for the removed sampl e s to determine the total 
amount released according to the following formula (32): 
2 
3 




. (C measJ. s 
Hanson Research Corp., Northridge, Cal ifornia . 
. (Eq . 6) 
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Where: 
C meas. is the spectrophotometrically measured concen-
n 
tration . 
C is the concentration of the nth sampling expected 
n 
in the medium if previous samples had not been 
removed . 
n-1 is the total volume of all samples remove d prior 
to the sample being measured. 
C meas. is the total of all spectrophotometrically s 
measured concentrations at n-l samples. 
The Cortisol concentration in distilled water was det e r-
mined by ultra violet spectrophotometry at wavelength 242 nm3 , 
and then by consulting the standard curve of Cortisol (Figure 
3). All studies were conducted in duplicates. 
Film Thi ckness Study: 
Films of different thicknesses were prepared by the use 
of the mercury substrate technique (23, 24). 5ml, 7ml, 9ml, 
11ml, and 13ml of the film-forming solution were poured on 
the surface of the mercury contained in the aluminum dishes, 
which then were partially covered with their lids. The 
partial covering of the dishes helped in controlling the rate 
of evaporation of the solvent, and prevented the blistering 
3 Spectronic 710, Bausch and Lomb, Rochester, New York. 
15 
of the deposited films. The larger amounts needed a longer 
time (up to 7 days) to completely dry up, than the small 
amounts. The dry films were carefully removed from the mer-
cury substra te and were individually stored between sheets 
of wax paper in a desiccator. 
The film thickness was measured by means of a Minitec-
4 
tor thickness measuring gauge (Model-N). The instrument 
was calibrated using the standard foils provided with the 
instrument. Ten readings were recorded at different points 
of the film surface. An average of twenty readings on two 
films of the same composition was recorded, and the standard 
deviation was calculated (Table II) . 
Povidone Release Studies: 
To test if the PVP was leache d out from the film matrix, 
a series of films (placebo and medicate d films) were pre-
pared the same way as in the other studies. The weights of 
the drug films were determined. The release studies were 
carried out using the same technique and the same apparatus 
used in the drug release studies whi c h were previously des-
cribed. After runni~g the experiment over 24 hours, the film-
coated petri dishes were taken out of the dissolution medium 
and dried in an oven at 50°C. The complete dryness of the 
films was confirmed by weighing the dishes to a constant 
4 Gardner Laboratory, Inc., Bethesda, Maryland. 
Tabl e I. Composition of films A and B. 
Material 
Povidone (% wjw) 
Lanolin al cohol (% wjw) 








2 . 5 
Table II. Volume s of solutio n and the result e d film 
thickness . 
Vo lume of So lution Dry f ilm thi c kness llm + S .D . 
5 ml 9 3 + 4.1 
7 ml 1 38 + 8. 6 
9 ml 219 + 8 . 7 
11 ml 317 + 12. 8 
13 ml 409 + 11 . 2 
16 
a 
a Mean + standard deviatio n of t e n me asure ments in dupl icates . 
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weight. Three ml of the bathing solution was withdrawn and 
analyzed spectrophotometrically to determine the amount of 
the drug released. The weight loss was determined and the 
amount of PVP leached out was calculated (Table III). The 
same experiment was performed using pure lanolin alcohol 
films to determine the possibility of dissolution of lanolin 
alcohol. 
Solubility of Cortisol in the Film Matrix: 
(I) Solubility of Cortisol in lanolin alcohol: 
First, the solubility of Cortisol in distilled water was 
determined by adding excess amounts of Cortisol to a known 
volume of water in 50-ml conical flask. A teflon-coated 
magnetic bar was placed in the flask prior to capping it 
tightly. The solution was left stirring for about 48 hours . 
The stirring was stopped prior to the sampling . An aliquot 
was filtered using 0.22 ~m filter paper. 5 The first few 
mls of filtrate were discarded due to the adsorption of the 
steroid to the filter paper (33). After proper dilution, the 
concentration of Cortisol was determined as usual . About 1.1 
gm of lanolin alcohol was melted in a preweighed 25-ml flask 
containing a known amount of Cortisol dissolved in 20 ml of dis-
tilled water (a saturated solution). A teflon-coated magnetic 
bar was placed in the flask, which was then capped and kept 
5 Swinnex-25, Millipore Filter Corp., Bradford, MA. 
18 
in a water bath at 37°C, over a magnetic stirrer. The flask 
was supported by a holder at a distance of 2 e m from the 
bottom of the bath. Th e stirring was stopped after 96 hours. 
The lanolin alcohol was allowed t o settle. An aliquot of 
the aqueous phase was filtered using a glass funnel with 
filter paper . One ml was pipetted into a 25-ml volumetric 
f l ask. Th e volume was adjusted to the mark. The drug con-
centration was measured spectrophotometrically as described 
before. The apparent solubility of the drug in lanolin 
alcohol was determined using the equation (Eq. 7). 
(II) Solubility of Cortisol in PVP: 
The solubility of Cortisol in ethyl acetate was determined 
the same way as in the experiment of the drug solubility in 
lanolin alcohol. One gm of PVP was suspended in a saturated 
solution of Cortisol in ethyl acetate in 50-ml conical flask, 
which was tightly capped and stirred magnetically. The 
stirring was stopped after 96 hours, a nd the PVP was allowed 
to settle. Ten ml of the filtered supernatant were pipetted 
into a 100-ml volumetric flask. The so l vent was evaporated 
in an oven at 55°C. The residue was dissolved in distilled 
water, and the resulting solution was properly diluted. The 
apparent partition coefficient K was determined by the e 
equ ation (Eq . 8) proposed by Chowhan e t al. (34). 
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(A) Lanolin Alcohol-Wate r: 
(A1 - A ) W 
K = e = 
w w w 
A W . . . . . . (Eq. 7) w 1 
Where: 
A1 and Aw are the amounts of drug in lanolin alcohol 
and water res pectively . 
A1 is th e initial amount of drug in water. w 
w
1 
and Ww are the wei ght s of lanolin alcohol and wa ter 
r espective ly . 












are t h e 
= 
(Ai - AE) WE 
AE Wp 
a mounts of drug 
acetate r esp ectively. 
is the initi a l amount of drug 
. . . . ( Eq. 8) 
in PVP a nd ethyl 
in ethyl ace tate . 
WP and WE are the we ights of PVP and ethyl acetate 
r espective ly. 
Since th e effective partition coeffi c i e nt rel a t es to the 
drug conce ntration in the two phases near saturat ion, the 
apparent solubility of the drug in PVP or lanolin alcohol 
can be determi ne d from the drug so lubility in wate r or 
ethyl acetate, us ing the fo rmul a: 
c P . .. 1 
s = K e 
CE . . . w 
s . . . . . . . (Eq. 9) 
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Where: 
c~·· · 1 is the apparent solubility in PVP or lanolin 
alcohol. 
CE ... w is the apparent solubility in ethy l acetate 
s 
or water. 
A control tes t was conducted using the same a mo un t of 
Cortisol in 50 ml e thyl acetate. The whole experiment was 
carried out in duplicate. 
Effect of PVP o n Cortisol Solubility in Water : 
Excess amounts of Cortisol were added to solutions of 
PVP in distill e d water. The PVP c once ntratio ns were 1, 5, 
10, 25, 30, a nd 40% (wjv), respective ly. The so lutio ns 
were kept in tightly covered beakers (ParafilmQD was used) 
and st irred by means of s tainless steel st irrers in the dis-
solution assembly de scribed previously. The temperature 
was kept at 37+0.5°C throughout the experiment . The stirring 
was stopped after 96 hours and the supernatants were fil -
tered by means of 0.22 ~m fi lte r paper . 6 One ml of each 
solution was pipetted out and properly di luted . The concen-
tration of the drug was measure d as described previously. 
The whole study was conducted in duplicate . 
6 Swinne x-25 , Millipore Filte r Corp., Bradford, MA. 
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Effect of Drug Concentration: 
The effect of the concentration on the drug release 
rate was tested using film A. The drug concentration was 
varied while keeping the proportion of film formers constant. 
The Cortisol concentrations were 0.5, 1.5, 2.5, 5, 7.5, 8.5, 
and 10% (wjw), respectively. The stirring speed was main-
o tained at 30 rpm and the temperature was kept at 37+0.5 C. 
:; I 1 r r ' · 
Table III. Composition of Lano l in Alcohol-PVP films at different Drug 
Concent r ations (% wjw) 
PVP 59 . 5 59.0 58.5 57.0 55.5 55 . 0 54 . 0 
Lanolin Alcohol 40.0 39.5 39 . 0 38.0 37.0 36 . 5 36 . 0 








Fi gur e 1. Appar atus used for i n vi tro rel ease s tudies. 
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Figure 3. Standard curve for Cortisol . 
RESULTS AND DI SCUSSION 
In this study, the release of Cortisol from lanolin 
alcoho l and lanolin al cohol-Pv~ films (Table I) was investi-
gated . The effects of agitation, film thickness and drug 
concentration on the rate of drug release have been care-
fully examined. The resulting drug release data were fur -
ther analyzed and interpreted in order to gain additional 
insight into the drug release mechanims. 
It was previously explained that the two Higuchi models 
(Eq. 1 and 2) describe drug release as being linear with the 
square root of time . 
- 1/2 Q - K t . . . . . . . . . . . . . . . . ( Eq . 3 ) 
Where: 
K is the release rate constant. 
For a homogeneous matrix : 
and for a granular matrix system: 
KG ~€ (2A - C ) C s s 
. . . . . ( Eq. 4) 
. . . . . ( Eq . 5) 
The data have been analyzed to test the applicability of this 
mode . 
Solubility of Cortisol in Film Matrix: 
The solubility of Cortisol in the film matrix was examined. 
The results ind i cated that after 96 hours of continuous 
26 
27 
stirring of Cortisol and lanolin alcohol in distilled water 
as described in the experimental section , Cortiso l was 
compl etely insolubl e in lanolin alcohol. Based o n the 
solubility o f Cortisol in ethyl acetate (3.2 mgjml), and 
by the use of equations 8 and 9, the apparent solubility 
o f Cortisol in PVP was cal c ulate d a nd found to be 6 . 34 mgjg . 
The attainment of equilibrium solubility in 96 hours was 
confirmed by the fact that there was no di fferen ce in 
absorbance between the samples analyzed at the end of 48 
hours and 96 hours. 
From the aforementioned results, i t was shown that the 
3 initial drug concentration in the matrix, A (30,41 mg jcm ) , 
was g r eat er tha n its solubility in the same mat rix by more 
than fo ur fo ld, (A >> C ) . 
s 
Effect of the Stirring Rate : 
The effect of agitation was studi ed at sti rring speeds 
of 0, 10, 30, 60, 90, 150, a nd 210 rpm at 37°C. The data 
are shown in Tables IV - XVII a nd Figures 4 - 10 . 
Upo n reviewing the effect of agitation on the r e l ease 
rate of t he drug from film A (Tables XVIII - XIX), it was 
observed that there is a sl i ght increase in t he release rate 
con s t ant with inc r easin g agitation up to 60 rpm followed by 
a slight dec line. Thi s fact was obser ve d with both the 
diffusion r elease r ate a nd the first-o rder r e l ease rate 
constants . I f the drug r e l ease fro m the film A followed 
t he diffusional process which was matrix controlled, one 
Table IV. Release of Cortisol from Unagitated Film A. 
Time (min.) Absorbance % Drug Released 
30 0.075 4.6 
60 0.103 6.4 
90 0.127 7.9 
120 0.153 9.7 
1 80 0.211 13.4 
240 0.264 16 .9 
300 0.285 18.4 
360 0.346 22.4 
420 0 .357 2:1.3 
480 0.395 25.9 
540 0.414 27.3 
600 0.449 29 . 8 
660 0.472 31.6 
720 0.507 34.0 
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Table V. Release of Cortisol from Unagitated Film B. 
Time (min.) Absorbance % Drug Released 
30 0.061 3.7 
60 0 . 121 7.5 
90 0.155 9.7 
120 0 . 186 11.6 
180 0.223 14 . 2 
240 0.254 16.3 
300 0 . 284 18 . 3 
360 0 . 302 19.7 
420 0 . 340 22 . 2 
480 0. 368 24 . 2 
540 0.383 25.4 
600 0.402 26 . 8 
660 0.415 27.9 
720 0 . 432 29 . 2 
1440 0.602 4 0 . 2 
I I I 
Cumulative 
Amount Released Q 2 
mg mgf cm 
0.459 0.010 
0 . 938 0.021 
l. 214 0.027 
1.469 0 . 033 
1.774 0.040 
2.038 0 . 046 
2.291 0 . 052 
2 . 458 0.056 
2.778 0 . 063 
3.027 0.069 
3.173 0.072 
3.353 0 . 076 
3 . 4 86 0.079 
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Figure 4 . Release of Cortisol from Unagitated Films A a nd B. 
Table VI. Release of Cortisol from Film A at Agitation Speed of 10 rpm . 
Cumulative 
Amount Rel eased Q 2 
Time (min) Absorbance % Drug Released mg mgjcm 
30 0 . 085 5.2 0 . 648 0.015 
60 0 . 138 8.6 1.081 0.025 
90 0 . 176 11.1 1.382 0 . 031 
120 0 .218 13.8 1.726 0.039 
180 0.281 17.9 2.238 0.051 
240 0.339 21.8 2.719 0.062 
300 0 . 375 24.2 3 . 027 0.069 
360 0.432 28.1 3 . 507 0 . 079 
420 0.472 30.8 3.855 0.087 
480 0.503 33 . 1 4.135 0.094 
540 0.547 36.2 4.520 0 . 102 
600 0.582 38.7 4.839 0.110 
660 0.617 41.3 5.160 0 . 117 
720 0.639 43.1 5.383 0 . 122 
1440 0.518* 68.3 8.535 0.193 
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Release of Cortisol from Film B at Agitation Speed of 10 rpm. 
Cumulative 
Amount Released 
Absorbance % Drug Released mg 
0.075 3.8 0.48 
0.112 6 . 0 0.743 
0.150 8.0 1.02 
0.183 10.0 1.26 
0.224 12.5 1. 57 
0 . 263 15.0 1.84 
0.287 16.0 2.03 
0.314 18.0 2.24 
0.329 19.0 2. 37 
0.353 20.0 2.56 
0.361 21.0 2.64 
0.386 22.7 2.84 
0.393 23 . 0 2 . 91 
0.410 24.0 3.06 
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Figur e ~. Release of Cortiso l f rom Films A and B, at 
Agitation Speed 10 rpm. 
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Table VIII. Release of Cortisol f r om Film A at Agitation Speed of 30 rpm. 
Cumulative 
Amount Released Q 2 
Time (min) Absorbance % Drug Released mg mgjcm 
30 0 . 086 5.3 0.657 0 . 015 
60 0.113 7.0 0.877 0.020 
90 0 . 155 9.7 1 . 215 0.028 
120 0 . 186 11.8 1 . 470 0.033 
180 0 . 249 15.9 1.983 0.044 
240 0 . 298 19.0 2.386 0 . 054 
300 0 . 369 23.7 2.967 0 . 067 
360 0.400 25.9 3 . 242 0.073 
420 0 .447 29.0 3 . 643 0.082 
480 0 .493 32.0 4.041 0.091 
540 0 . 547 36.0 4.502 0.102 
600 0 . 582 38.6 4.821 0.109 
660 0.624 41.6 5 . 200 0.118 
720 0.647 43.4 5 . 428 0.123 
1440 0.565* 74 . 1 9.262 0.210 
-
* · Proper dil u tion was made . 
w 
.+::>. 
Tab l e I X. 
















I ! i I I _ I . I I I I .. . I 
Release of Co r tisol f r om Film B at Agi tation Speed of 30 r pm. 
Cumulat i ve 
Amount Released Q 2 Ab sorbance % Drug Re l eased mg mgjcm 
0.077 4.7 0 . 585 0.013 
0 . 120 7. 4 0.930 0.021 
0.156 9.8 1 . 221 0 .028 
0. 1 80 11 .4 1.422 0.032 
0.226 14.4 1.799 0.041 
0.252 16.2 2.021 0.046 
0 . 281 18.1 2. 268 0.051 
0.304 19.8 2.473 0.056 
0.333 21.8 2 . 725 0 . 062 
0 . 347 22.9 2 . 862 0 . 065 
0. 366 24 . 3 3 . 036 0.069 
0.381 25 . 5 3.185 0.072 
0.394 26.5 3 . 317 0 . 075 
0.405 27.5 3.434 0.078 
0 . 558 37 . 4 4.669 0.106 
w 
CJl 
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Figur e 6. Rel ease of Cortiso l from Films A and B, at 
Agitation Speed 30 rpm. 
36 
I [!. ·--' i I I : I i I ' 1 I . I I 
Table X. Release of Cortisol from Film A at Agitation Speed of 60 rpm . 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgj cm 
30 0.106 6.5 0.813 0.018 
60 0.170 10.6 1 . 325 0.030 
90 0.230 14.5 1.812 0 . 041 
120 0 . 270 17.2 2.145 0.049 
180 0.356 22.7 2.841 0 . 064 
240 0.418 26.8 3.355 0.076 
300 0.475 30.7 3.838 0.087 
360 0.531 34.5 4.316 0.098 
420 0.589 38.5 4. 817 0.109 
480 0.636 41.6 5 . 232 0.118 
540 0.679 45.0 5.621 0.127 
600 0.727 48.4 6 . 052 0 .1 36 
660 0.758 50.8 6.352 0 .144 
720 0.805 54.2 6.781 0 .15,3 
1440 0.597* 79.1 9.889 0.224 
-
* · Proper dilution was made. 
w 
...;j 
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Table XI. Release of Cortisol from Film Bat Agitation Speed of 60 rpm. 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgfcm 
30 0.104 5.7 0.724 0.016 
60 0.156 8.4 1.05 0.024 
90 0.192 10.5 1.32 0.030 
120 0.232 12.9 l. 61 0.037 
180 0.290 16 . 2 2.03 0 . 046 
240 0.332 19.0 2.38 0.054 
300 0.368 21.0 2.65 0 . 060 
360 0.412 24.0 2.99 0.068 
420 0.444 26.0 3.24 0.073 
480 0.459 27.0 3.39 0.077 
540 0.496 29.0 3.66 0.083 
600 0.535 31.7 3 . 97 0.090 
660 0. 534 32.0 4.00 0 . 091 
720 0.548 33.0 4.13 0.094 
1440 0.792 47 . 0 5 . 88 0.133 
w 
00 
• Film A 
• Film B 
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Figure 7. Release of Cortisol from Films A and B, at 
Agitation Speed 60 rpm. 
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Table XII. Release of Cortisol from Film A at Agitation Speed of 90 rpm . 
Cumulative 
Amount Released 
Time (min.) Absorbance % Drug Released mg 
30 0.085 5.2 0.648 
60 0 . 128 7 .9 0.994 
90 0 .160 10 . 0 1 . 255 
120 0.194 12.3 1.535 
180 0 . 248 15 . 8 1 .976 
240 0.301 19.3 2.412 
300 0.350 22 . 6 2.823 
360 0.409 26 . 5 3. 312 
420 0.441 28.8 3.596 
480 0.485 31.8 3.979 
540 0 .525 34.7 4.332 
600 0.564 37.4 4.679 
660 0.594 39.8 4.960 
720 0.622 41.8 5.226 
1440 0.517* 67.7 8.467 
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Release of Cortisol . from Film B at Agitation Speed of 90 rpm. 
Cumulative 
Amount Released 
Absorbance % Drug Released mg 
0.085 4.4 0.549 
0.127 6 . 8 0.848 
0 .161 8.8 1.10 
0.184 10 . 0 1.27 
0.227 12.6 1. 58 
0.281 15.8 1.97 
0.307 17 .4 2.17 
0 . 339 19 . 4 2.42 
0.374 21.5 2.69 
0 . 372 21.6 2.70 
0 . 427 24.9 3.11 
0.441 25.9 3 .24 
0.455 27.0 3.38 
0.481 28.7 3.59 
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Figure 8 . Release of Cortisol from Films A and B, at 
Agi tation Speed 90 rpm. 
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Table XIV. Release of Cortisol from Film A at Agitation 
Time (min.) Absorbance % Drug Released 
-
30 0.084 5.1 
60 0.127 7 . 7 
90 0.155 9 . 7 
120 0.188 11.9 
180 0.240 15.3 
240 0.290 18 . 6 
300 0. 342 22 . 1 
360 0. 383 24.8 
420 0 . 423 . 27.6 
480 0.462 30.3 
540 0.499 32.9 
600 0 . 536 35.6 
660 0.562 37 . 6 
720 0 . 596 40.0 
1440 0.508* 66.4 
* · Proper dilution was made. 
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Release of Cortisol from Film B at Agitation Speed of 150 rpm. 
Cumulative 
Amount Released Q 2 
Absorbance % Drug Released mg mgfcm 
0 . 094 5.0 0 . 612 0.014 
0 . 137 7.0 0.918 0.021 
0.174 9.5 1.19 0.027 
0.211 11.7 1.46 0.033 
0.240 13.0 1.67 0.038 
0.269 15.0 1 .89 0.043 
0. 302 17.0 2.15 0 . 049 
0.332 19.0 2. 38 0.054 
0.350 20.0 2 .52 0.057 
0.381 22 . 0 2.76 0.063 
0.396 23.0 2 .90 0.066 
0.413 24.0 3.04 0.069 
0.433 25.7 3.21 0.073 
0.476 28.0 3.54 0.080 
0.664 39 . 0 4.89 0.111 
~ 
~ 
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Figure 9 . Release of Cortisol from Films A a nd B, at 
Agitation Speed 150 rpm . 
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Table XVI. Release of Cortisol from Film A at Agitation Speed of 210 rpm. 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released . mg mgjcm 
30 0.084 5.0 0 . 642 0 . 0 15 
60 0.125 7.8 0 . 969 0 . 022 
90 0.149 9 . 3 1 . 168 0.026 
120 0.181 11.5 1 . 432 0.032 
180 0.232 14.8 1.848 0 .042 
240 0.282 18.0 2.259 0.051 
300 0 . 320 20.6 2.581 0 . 058 
360 0.358 23.2 2 . 906 0 . 066 
420 0.396 25.8 3.231 0.073 
480 0 .431 28 . 3 3.538 0 . 080 
540 0.469 31.0 3.871 0 . 088 
600 0.504 33 . 5 4 .184 0 . 095 
660 0.528 35.3 4.413 0 .100 
720 0 . 575 38.6 4 . 823 0 .1 09 
1440 0.521* 68.2 8.522 0 . 193 
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Release of Cortisol from Film B at Agitation Speed of 210 rpm. 
Cumulative 
Amount Released 
Absorbance % Drug Released mg 
0.074 4.0 0.471 
0.121 6.0 0.806 
0.156 8 . 0 1 . 06 
0.185 10.0 1.27 
0.219 12 .0 1.52 
0.254 14.0 1.78 
0.285 16.0 2.02 
0 . 308 18 . 0 2.20 
0.336 19 .0 2.41 
0.356 20.6 2.58 
0.360 21.0 2.63 
0.381 22.0 2.8 
0.395 23.0 2.93 
0.408 24.0 3 . 04 
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Figure 10 . Re lease of Cortisol from Films A and B, at 
Agitation Speed 210 rpm. 
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Table XVIII. Q vs t 112 Treatment of Data for Release of Cortisol from Film A 
at-nifferent Agitation Speeds. 
Agitation Speed K X 10-
3 Lag Time Correlation 
(rpm) (mgjcm 
2 . 1/2) (min . ) Coefficient m1n 
Zero 4 . 2 20.3 0.995 
10 5.4 16 . 0 0.997 
30 5.9 26.9 0.989 
60 6.4 12 . 3 · 0.999 
90 5.3 20.9 0.994 
150 5.0 25.0 0.991 
210 5.2 25 . 0 0.981 
.+:>. 
en 
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Table XIX. First- order Treatment of Data for Release of Cortisol from Film A 
at Different Agitation Speeds. 
Agitation Speed k X 10- 3 Lag Time Correlation 
(rpm) -1 (min . ) (min. ) Coefficient 
Zero 0 . 517 0 . 6 0.998 
10 0.750 2.4 0.999 
30 0.883 -0.24 0.993 
60 l. 03 0.26 0.999 
90 0 . 733 -2 . 2 0.999 
150 0.717 0.66 0.998 
210 0.733 -0.17 0.990 
c.n 
0 
Table XX. Q vs t 112 Treatment of Data f or the Release of Cortisol from Film B 
at-nifferent Speeds. 
Agitation Speed K X 10- 3 Lag Time Correlation 
(rpm) (mgjcm 
2 . 1/2 ) (min. ) Coefficient m1n. 
Zero 3.2 1.13 0.998 
10 2.8 0.002 0.996 
30 2.9 0.05 0.997 
60 3.7 0.73 0.999 
90 3.2 3.1 0.999 
150 3.0 0 . 025 0 . 998 
210 2.6 0.006 0.997 
01 
...... 
Table XX I. First- Order Treatment of Data for t h e Release of Cortisol f r om Film B 
at Different Speeds. 
Agitation Speed k X 10- 3 Lag Time Correlation 
(rpm) - 1 (min. ) (min . ) Coefficient 
Zero 0.333 0.55 0 . 972 
10 0 . 250 3 . 84 0 . 958 
30 0 . 333 2.88 0 . 967 
60 0.417 - 10.2 0 . 980 
90 0 .333 0.6 0 . 983 
150 0.317 1.6 0.999 




could expect the release rate to be independent of the 
agitational changes in the release medium . The results 
clearly show that at least at low agitational speeds, a sur-
face diffusion layer-controlled release mechanism is opera-
tive rather than matrix-controlled diffusion. 
As can be seen from Tables XVIII - XIX the correlation 
coefficient of the square root of the time plots is not as 
high as those of the corresponding first-order plots. Fur-
thermore, the lag times (time intercept extrapolated to 
Q = 0) of Q vs t 112 plots are much higher than those of the 
corresponding first-order plots. 
Q vs t 112 treatment of the data for film B is shown in 
Table XX. The corresponding first-order treatmen t of the 
data is shown in Table XXI. It is clear that the linear 
square root of the time plots has high correlation coef-
ficients; and the observed lag times were very small. More 
significiantly, the Higuchi constant K is independen t of the 
change in agitation intensity. On the other hand, lower 
correlation coefficients and higher lag times were obtained 
with the first-order treatment of data. 
Film Thickness Study : 
Series of films (film A) of different thicknesses 
Table II were investigated for drug release at 37°C. The 
data is shown in Tables XXII - XXVI and the corresponding 
II : I I -, ,. ( I I . 1. I I 
Table XXII. Release of Cortisol at Film Thickness of 93 ~m + 4.6.a 
--
Cumulative 
Amount Release d Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.086 5.3 0 . 657 0 . 0 15 
60 0.113 7.0 0.877 0.020 
90 0 . 155 9.7 1.215 0.028 
120 0 . 186 11.8 1.470 0.033 
180 0.249 15.9 1.983 0 . 044 
240 0 . 298 19.0 2.386 0.054 
300 0.369 23 . 7 2.967 0.067 
360 0.400 25.7 3 . 242 0 . 073 
420 0.447 29.0 3.643 0.082 
480 0.493 32.0 4.041 0.091 
540 0.547 36.0 4.502 0.102 
600 0.582 38.6 4 . 821 0.109 
660 0 . 624 41.6 5 . 200 0.118 
720 0.647 43.4 5 . 428 0.123 
1440 0.565b 74.1 9 . 262 0 . 210 
~ : Mean+ SD of ten measurements. 
c.n 
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Figure 1 1. Release of Cortisol fro m Film A at Thic~ness 
of 93 lJm. 
Table XXIII. Release of Cortisol at Film Thickness of 138 llm ~ 8.6 . a 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.061 2.6 0.459 0.010 
60 0.103 4.5 0.794 0.018 
90 0 .165 7.4 1.291 0.029 
120 0.229 10.3 1.807 0.041 
180 0.326 14.8 2.587 0 . 059 
240 0.417 19.1 3.339 0 . 076 
300 0.491 22.5 3.944 0.089 
360 0.533 24.7 4 . 316 0.098 
420 0 .598 27.8 4.867 0 .110 
480 0.635 29 . 7 5.205 0.118 
540 0 . 689 32.5 5.681 0.129 
600 0.731 34.7 6.065 0.137 
660 0 . 782 37.3 6.524 0.148 
720 0.878 42 .0 7.342 0.166 
1440 0. 665b 62.6 10.95 0 . 248 
a : Mean + SD of ten r eadings in duplicat e. 
C}l 











0 10 20 30 40 
fi , ,j minutes 
Figure 12. Release of Cortisol from Film A at Thickenss of 
138 vm. 
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Table XXIV. Release of Cortisol at Film Thickness of 219 llm + 8.7. a 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.069 2.2 0.498 0.011 
60 0.123 4.2 0 . 953 0.022 
90 0.189 6.6 1 . 482 0.034 
120 0.214 7.5 1.694 0.038 
180 0.309 10.9 2.458 0 . 056 
240 0.424 15.1 3 . 388 0.077 
300 0.470 16.8 3 . 781 0 . 086 
360 0.539 19.4 4. 361 0.099 
420 0.578 20.9 4 . 712 0 .107 
480 0 . 635 23.1 5.205 0 . 118 
540 0 . 697 25.5 5 .743 0 .1 30 
600 0.729 26.9 6.05 0.137 
660 0.765 28.4 6.389 0.145 
720 0.809 30.2 6 . 797 0.154 
1440 0.618b 44.9 10 . 11 0 . 229 
~ : Mean + SD of ten readings in duplicate. CJI 
00 
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Figure 13. Re l ease of Cor t i so l f r o m F i l m A at Film 
Th ickness of 219 ~m . 
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Table XXV. Release of Cortisol at Film Thickness of 317 llm + 12.8. a 
Cumulative 
Amount Released Q 2 
Time (min . ) Absorbance % Drug Released mg mgjcm 
30 0.079 2 . 2 0.60 0.014 
60 0 . 141 4.0 1.095 0.025 
90 0.192 5.5 1.508 0.034 
120 0.222 6.4 1.760 0.040 
180 0 . 307 8.9 2.446 0.055 
240 0.400 11.6 3 . 202 0.072 
300 0.483 14.1 3.885 0 . 088 
360 0.550 16.2 4.450 0.101 
420 0.612 18.1 4.982 0.113 
480 0.660 19.7 5.408 0.122 
540 0.703 21.1 5.799 0.131 
600 0.725 21.9 6.025 0 .1 36 
660 0 . 766 23.3 6.406 0.145 
720 0.439b 26.6 7.327 0 .166 
1440 0 . 640 38.4 10.56 0.239 
Cj) 
a : Mean + SD of ten readings in dupli cates. 0 
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Figure 14. Release of Cortisol from Film A at Thickness 
of 317 llm. 
I I I ' 1 ! I I ! 1 
Table XXVI. Release of Cortisol at Film Thickness of 409 ]Jm + ll . 2.a 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.078 1.8 0.594 0 . 013 
60 0.139 3 . 3 1.080 0.024 
90 0 . 190 4 . 6 1.493 0.034 
120 0.239 5.8 1.891 0 . 043 
180 0 . 345 8 . 4 2.744 0.062 
240 0.424 10.4 3.395 0.077 
300 0.516 12.8 4.151 0.094 
360 0.590 14.7 4.774 0.108 
420 0.664 16.6 5.402 0.122 
480 0.709 17.9 5 . 808 0.131 
540 0 . 754 19.1 6 . 217 0 . 141 
600 0.817 20.8 6.775 0.153 
660 0 . 866 22.2 7.223 0.163 
720 0.490b 25.1 8.170 0.185 
1440 0.679 34.4 11.17 0.253 
m : Mean ~ SD of ten readings in duplicate . 0') 
tv 
b : Proper dilutions were made. 
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Figure 15. Release of Cortisol from Film A a t Th i ckness 
of 409 ~1m. 
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plots in Figures 11- 15. According to Higuchi's diffusion-
controlled mechanism of drug r e lease, the release rate con-
stant K has the dimensions of weight per area per square r oot 
of time and should be independent of f ilm t h ickness . The 
approximate constancy of K with varie d film thickness 
is shown in Table XXVII. 
It was r e porte d (19, 20) that the fi l m thi ckness does 
affect the duration of the drug release. The time required 
for the r e l ease of hal f of the amount of the drug present in 
the film, the product h a l f -li fe (t
112
), was s h own to be r e -
lat e d to the film thickness by the fo llowin g relationship 
de rived from Eq. 5: 
... (Eq. 10) 
Where: 
A: Initial drug concentratio n in the f i lm matrix. 
h: Film thickness . 
K: Release rate constant (Higuchi). 
The results shown in Table XXVIII indicate that the 
t
112 
values calculated by the first-order r e l ationship : 
Wh e r e: 
0 .693 
k 
k is the fi rst-order r ate constant. 
. . ( Eq . 11) 
and muc h more accurate in the predicting the time for r elease 
of 50% of the original amount of the drug in the f ilm. That is 
Table XXVII. 
Film thickness 
~m .:!: S . D. 
a 
93 + 4 . 1 
138 + 8.6 -
219 + 8.7 -
317 + 12.8 
409 + ll. 2 -
Table XXVI I I . 
Film thickness 
a 
~.r.m + S.D. 
93 + 4.1 
138 + 8 . 6 -
219 + 8.7 
31 7 + 12 . 8 -
409 + 11.2 
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1/2 Q vs t Treatment of Data for Release of 
Cortisol from Film A as a Function of Film 
Thickness. 
K X l0 - 3 t1/2 (min . ) 
(mgjcm 
2 . 1/2) Measured Calculated m1n. 
5 . 9 870.3 574 . 4 
7.4 1024 683.1 
7.0 1722.3 1323 . 1 
7 . 1 2256 . 3 1922.9 
7. 8 2601 2106.8 
First-Orde r Treatment of Data of Re lease of 
Cortiso l from Film A as a Function of Film 
Thi ckness. 
k X 10- 3 t 1 L2 (min . ) 
-1 (min. ) Measur ed Calculated 
0.883 792 784 . 8 
0.667 1056 1039 
0.417 1716 1661. 9 
0 . 333 2052 2081 . 1 
0.300 2328 2310 
a Mean + standard deviation of ten measureme nts .· 
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confirmed by the small variation between calculated and 
measured t 112 by first-order analysis (Table XXVIII) . On 
the other hand, it is clear that this variation is ver y 
high. Whe n t
112 
is cal culat e d by Q vs t 11 2 treatment Table 
XXVII I . Th e first-order rat e con s tant k i s depe ndent on 
film thickness. 
PVP Rel ease Studies: · 
Placebo and med i cated films were prepared by t he pre-
viously described technique and we re t ested fo r t he l oss of 
PVP during the drug rel ease perio d at 37°C. As can be see n 
from Table XXIX, a s i gn ificant amount of PVP was l eached 
out from both the place bo and the me di cat ed fi lms . The 
loss of PVP was substantially gr eater from t h e medicate d 
films than from the placebo. It would appear that the in-
corporation of Cortisol e nhanced the l oss of PVP. 
Hi gu c hi (30) s uggested t hat the fi lm matrix shou l d r e -
main intact throughout the release process in o rde r to 
validate one of the Hi gu chi mode ls . The presence of · com-
plications such as partial disso lutio n of t he mat rix s ub-
sta n ce , weakens the possibility of the application of e i ther 
one of the two Higuc hi mode l s . The observed results and 
subsequent analysis are con s ist e n t with this expectation . 
Films of pure lano l i n a l cohol (Film B) wer e checke d for the 
possibil ity of loss of lanolin alcohol in the dissolution 
me dium . It i s clear from Tabl e XXX tha t a n egli g ible 
Table XXIX. Loss of PVP from Placebo and Medicated Film in the Bathing Fluid over 24 Hours . 
Weight of Weight of Dry Loss Amount of Amount of Original 
Dry Film Film After Re- Weight Cortisol PVP Amount PVP 
Film mg lease (24 hr) mg Released Released of PVP Lost 
mg mg mg mg % 
·-
Placebo 0.5096 0.4493 0 . 0603 - 0.0603 0.3058 19.7 
(I) 
Placebo 0.5033 0.4389 0 . 0644 - 0.0644 0.3020 21.3 
(I I) 
Mea n 0.5065 0.4441 0 . 0624 - 0 .0624 0.3039 20.5 
AI 0.4999 0.3914 0.1085 0.0085 0.10004 0.2924 34.2 
BI 0.5021 0. 3926 0 . 1095 0.0092 0 . 1003 0.2937 34.15 
Mea n 0.501 0.3920 0 . 109 0.0089 0 . 1002 0. 2931 34.19 
(J) 
---l 
. - I ' ' I I I ' I I 
----------~--------~~_. ____ __ 
Table XXX. Loss of Lanolin Al coho l From Fi lm B. 
Weight of Weight of Dry Amount 
Dry Film Film After Lost 
Film gm Release Study gm 
( gm) 
Film 0.4869 0.4786 0.0083 
BI 
Film 0.4822 0.4739 0.0083 
BII 
Mean 0. 4846 0.4763 0.0083 
Amount of Amount of 
Cortisol Lano lin 
Lost Alcohol 
( gm) Lost 
(gm) 




















amount (0.8%) of the film matrix was lost durin g the re-
lease period. 
Effect of PVP on Cortisol Solubility in Water: 
69 
The solubility of Cortisol in distilled water was de-
termined at 25°C an d at 37°C (Tabl e XXX I). PVP was found 
to e nhance t he solubility of Hydrocort iso n e in water (Table 
XXXI I a nd Fi gure 16) : Simonelli et al. ( 35) have reported 
that co-precipitation of drugs with PVP can signi ficantly 
increase t h e dissolution a nd the apparent so lubility of a 
given drug . The results of another interesting report (36) 
have s u ggest e d that a hi gh e ner gy form of Cortisol, with a n 
activity of 14-15 times that of the pure drug is present in 
the PVP-Cortisol co-precipitate. The formation of Corti so l-
PVP co-precipita te is possible during the film pre paration. 
Thus it would appear that both Cortisol and PVP influence 
each other ' s dissolutio n profile favorably. 
Effect of Drug Concentration: 
The effect of the c hange in drug conce n tration o n the 
release rate constants K and k was investigated over a wide 
range of drug co ncentr at i o ns (0.5 - 10% wjw, Table III) at 
37°C. The rel ease data a r e shown in Tables XXX I I I - XXX I X a nd 
Figures 17 - 23. Q vs t 112 treatments of dat a fo r drug 
release at various concentrations are s hown in Table XXXX. 
Th e correspondin g first-order treatments of data a r e shown 
in Table XXXX I . The fi r s t-orde r plots are shown in Figures 
24 and 25. Although the s quar e root o f time p l ots ha ve 
70 
Table XXXI . Solubility of Cortisol in Water at Different 
Temperatures . 
Solubility of Cortisol (mgjml) 
Reported Experimentalc 
At 25°C 0.280a 0.298 
At 37°C 0. 543b 0.532 
a Reference (37) 
b Reference (29) 
c Mean of duplicate trials. 
Table XXXII. Effect of PVP on Cortisol Solubility in Water. 
PVP Concentration Cortisol Solubility (mgjml)a 
(% wjv) at 25°C at 37°C 
1.0 0.520 0.540 
5.0 0 . 622 0.707 
10 . 0 0 . 720 0 . 958 
25.0 0.985 1.60 
30.0 1.250 1. 72 
40.0 1.310 2 . 3 
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Fi gure 16. Effect of PVP on Cortisol Solubility in Water 
at 37oc. 

















I r ' 
Release of Cortisol at Concentrat i on of 0 . 5% (wjw). 
Cumulative 
Amount Released Q 2 
Absorbance % Drug Released mg mgjcm 
0 .057 17.0 0 . 429 0.010 
0.058 18 . 0 0.439 0 . 010 
0 .068 21. 0 0.525 0 . 012 
0. 081 25.0 0.632 0 . 014 
0.098 31 .0 0.770 0 . 017 
0.113 36.0 0.898 0 . 020 
0.130 42.0 1.038 0.023 
0 . 122 39.0 0.985 0.022 
0 . 126 41.0 1 . 028 0 . 023 
0 .134 44.0 1.10 0.025 
0.135 45.0 1.12 0.025 
0.151 50 . 0 l. 25 0.028 
0 . 151 51 . 0 l. 27 0.029 
0.157 53.0 l. 33 0.030 
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Figure 17 . Release of Cortisol from Film A at Concentra-
tio n of 0. 5% (wjw). 
' : I I I I 
Table XXXIV. Release of Cortisol at Concentration of 1.5% (wjw). 
Cumulative 
Amount Released Q 2 Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.070 7.0 0. 531 0 . 012 
60 0.109 ll.O 0.842 0.019 
90 0.141 15.0 1.10 0.025 
120 0.161 17.0 1.27 0 . 029 
180 0.182 19.0 1.45 0.033 
240 0.229 24.0 1.83 0.041 
300 0.259 28.0 2 . 09 0.047 
360 0.285 31.0 2.31 0.052 
420 0 . 323 35.0 2.63 0.060 
480 0. 336 37.0 2.76 0.063 
540 0.359 40 .0 2 . 97 0.067 
600 0.394 44.0 3 .27 0.074 
660 0.398 44.4 3.33 0.075 
720 0.409 46.0 3.45 0.078 
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Figure 18 . Release of Cortisol from Film A at Concentra-
tion of 1.5% (wjw). 
11 I I ' I I : . 
Table XXXV . Release of Cortisol at Concentration of 2.5% (wjw) . 
-
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mg jcm 
30 0.086 5 . 3 0.657 0 . 015 
60 0.113 7.0 0.877 0 . 020 
90 0 . 155 9.7 1.215 0 . 028 
120 0 . 186 11.8 1.470 0 . 033 
180 0.249 15 . 9 1.983 0 . 044 
240 0 . 298 19.0 2 . 386 0 . 054 
300 0.369 23.7 2.967 0 . 067 
360 0 .400 25.7 3 . 242 0 . 073 
420 0.447 29.0 3.643 0 . 082 
480 0 .493 32.0 4.041 0 . 091 
540 0 . 547 36.0 4.502 0 . 102 
600 0 . 582 38.6 4 . 821 0.109 
660 0.624 41.6 5.200 0.118 
720 0.647 43 . 4 5 . 428 0 .123 
1440 0. 565* 74.1 9 . 262 0 .210 
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Figure 19. Re l ease of Cortisol from Film A at Concentra-




Table XXXVI . Release of Cortisol at Concentration of 5% (wjw). 
-
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.179 5.6 1.389 0 . 032 
60 0.282 8.6 2.213 0.050 
90 0.384 12 . 2 3.039 0.069 
120 0 .497 15.8 3.957 0.090 
180 0.657 21.0 5.256 0.119 
240 0.770 24.8 6.195 0.140 
300 0.460* 29.7 7.417 0.168 
360 0.514 33.4 8. 341 0.189 
420 0.559 36.5 9.134 0 . 207 
480 0.606 39 . 8 9.960 0.225 
540 0.665 43.9 10.98 0.249 
600 0.456* 45.5 11.37 0.257 
660 0.480 48 . 2 12.05 0.273 
720 0.518 52.2 13.05 0.295 
1440 0.651* 85.7 21.41 0 . 485 
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Figure 20 . Release of Cortisol from Film A, at Concentra-
tion of 5% (w/w). 
. • f - . - I I I . ~ 
Table XXXVII. Release of Cortisol at Concentration of 7 . 5% (wjw). 
Cumulative 
Amount Released Q 2 
Time (min . ) Absorbance % Drug Released mg mgjcm 
30 0 .620* 25.9 9.72 0.220 
60 0.883 37.2 13.96 0.316 
90 0 . 659* 41.9 15.73 0 . 356 
120 0.667 42.9 16.08 0.364 
180 0.713 46 . 2 17.32 0.392 
240 0.758 49 . 5 18.56 0 . 420 
300 0.788 51.8 19 . 44 0.440 
360 0.821 54.4 20.41 0 . 462 
420 0.869 56.0 21.71 0.492 
480 0.875 58.9 22.09 0.500 
540 0.901 61.0 22.89 0 . 518 
600 0.874 59.4 22.27 0.504 
660 0 . 722* 66.0 24.74 0.560 
720 0.720 66.5 24.92 0.564 
1440 0 . 876 80.1 30.04 0 . 680 
-
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Figure 21. Release of Cortisol from Film A, at Concentra-
tion of 7.5% (wjw). 
Table XXXVIII . Release of Cortisol at Concentration of 8.5% (wjw). 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.575* 21.2 9.012 0.203 
60 0.581* 32.4 13.75 0.311 
90 0 .479* 35.8 15.23 0. 345 
120 0.410* 38.6 16.41 0.371 
180 0.449 42.6 18.10 0.410 
240 0.477 45.6 19.39 0.439 
300 0.505 48.6 20.67 0.468 
360 0.530 51. 4 21. ·86 0.495 
420 0.547 53 . 5 22 . 72 0.514 
480 0.576 56.7 24 . 08 0 . 545 
540 0.582 57 . 8 24 . 54 0 . 555 
600 0.594 59.4 25.25 0.572 
6 60 0.609 61 . 3 26.07 0.590 
720 0.621 63.0 26 . 79 0 . 606 
1440 0.638* 76.9 32.69 0.740 
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Figure 22. Release of Cortisol from Film A, at Concen tra-
tion of 8.5% (wfw) . 
I I I .. - I : ' 
Table XXXIX. Release of Cortisol at Concentration of 10% (wjw). 
Cumulative 
Amount Released Q 2 
Time (min.) Absorbance % Drug Released mg mgjcm 
30 0.899* 28.0 14.11 0.319 
60 0.806* 38.4 19.19 0.434 
90 0.642* 40 . 9 20 . 47 0 . 463 
120 0 . 551* 44.2 22.12 0.501 
180 0.588 47.6 23.79 0 . 538 
240 0.615 50 . 2 25.08 0 .568 
300 0.627 51.6 25.79 0.584 
360 0.645 53 . 5 26.75 0.605 
420 0 . 667 55.7 27.87 0 . 631 
480 0.690 58.1 29.04 0.657 
540 0.711 60.3 30.14 0.682 
600 0.721 61.6 30 . 81 0.697 
660 0.734 63 . 2 31 . 60 0.715 
720 0.750 65.0 32 . 52 0.736 
1440 0.806* 82.7 41.35 0.936 
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Figure 23. Re l ease of Cortisol from Film A, at Concentra-
tion of 10% (wjw). 
I _ . ' n 
Table XXXX. Q vs t 112 Treatment of Data for Release of Cortisol from Film A 
at-nifferent Drug Concentrations. 
Drug Concentration K X 10-
3 Lag Time Correlation 
(wjw) (mgjcm
2 min. 1 / 2 ) (min. ) Coefficient 
0 . 5% 1.00 -7.2 0.992 
1.5% 3.20 5.4 0.998 
2.5% 5.9 26.9 0.989 
5.0% 12.0 14.8 0.998 
7.5% 13.0 -162 .7 0.982 
8.5% 16.0 -96 . 6 0.989 
10.0% 17 .0 -145.2 0 . 990 
00 
0) 
I I , . . . I I . I 
Table XXXXI. First-Order Treatment of Release Data of Cortisol from Film A 
at Different Drug Concentrations. 
Drug Concentration k X 10-3 Lag Time Correlation 
(wfw) 
-1 (min. ) (min.) Coefficient 
--
0.5% 0.883 4.56 0.992 
1.5% 0.767 1.68 0.998 
2.5% 0.883 -0.24 0 . 993 
5 . 0% 0.950 0.38 0.998 
7.5% 0.867 0.24 0.981 
8.5% 0.817 -4.62 0 . 979 




relatively high correlation coefficients. Table XXXX, the 
observed lag times were relatively high. The deviation from 
the origin became progressively worse with increasing drug 
concentration. On the other hand, r elatively high correla-
tion coefficients were also obtained for the first-order 
treatments of the release data. The calculated lag times 
were very small and the first-order rate constants were in-
dependent of drug concentration as was confirmed by the 
parallelism of the first-order plot s (Figures 24 and 25). 
The films containing 7.5% wjw or more of Cortisol showed a 
significant burst effect due to the presence of the surface 
drug, while the films containing 5% wjw or l ess of Cortisol 
appear to r e l ease the drug more slowly initial ly. 
From the studies conducted on film A, it has been des -
cribed how Higuchi's release rate constant k was changing 
with the c hange in speed of agitation. Moreover, PVP 
has been fo und to leach out to the extent of 34%. A careful 
examination of Q vs t 112 plots seems to suggest a curvi-
linear r e lationship rather than the expected linearity. All 
this data appears to discount the possibility of a matrix-
controlled diffusion theory to such a film system. Further 
evidence of the invalidity of this mechani s m is that the 
rate of r e l ease is not inversely proportional to the total 
amount of the drug released, Q, as predicted by Eq. 12 
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Figur e 24 . Firs t-o rde r plo t s of Co rtis ol , Re l ease f rom 
Film A, at Co n centra tio ns of 0. 5% ( • ), 1. 5 % ( e ) , 5~b (.A. ) a n d 8 . 5% w j w ( e ) . 
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Figure 25. First-order Plots of Cortisol Release from 
Film A, at Concentrations of 2.5% ( • ), 




dt . . . . . . ( Eq. 12) 
The following first-order relationship 
kt log x = log X- 2 . 303 ......... (Eq . 13) 
Where: 
x is the drug content of the film at time t. It pre-
diets a direct proportionality between the rate of release 
and that any amount of drug released as suggested by the 
following equation: 
dQ -dt - kX - kQ . . . . . . . ( Eq. 14) 
When the rate of release is plotted as a function of Q, 
and 1/Q, linearity was not obtained with either o ne of the 
two mechanisms (Figure 26) . Final evidence against the 
applicability of a ma trix controlled diffusion mechanism is 
provided by plotting log Q vs log t, based on the logarithmi c 
form of Eq. 15: 
log Q = log K + 1/2 log t . . . . . . ( Eq. 15) 
Such a plot should have a slope of 0.5. However, the observed 
slope was 0.70 (Figure 27). These findings suggest that the 
drug release rate from Film A does not follow the matrix-
controlled diffusion model, but that a different mechanism 
might indeed be operative. Additional studies might be help-
ful in delineating the precise mechanism. 
By reviewing the data obtained from the drug release pro-
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Figure 26. Plots of Release Rate of Cortisol fro m Film A 
Vs . t he amou nt of drug r e l ease (Q) ( ~ ) . and 
the reciprocal of the amount of drug r e l ease 
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Figure 27. Relationship of log Q to log t, of Cortisol 
from Film A (slope= 0 . 70) . 
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Figure 28 . Plots of Release Rate of Cort isol from Film B, 
Against the Amount of Drug Release (Q) ( e ) 
and the Reciprocal of the Amount of Drug 
Re lease ( 1/Q) ( A ) . 
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Figure 29. Relationship of log Q to log t, of Cortisol 
Release from Film B (slope= 0.53) . · 
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intact throughout the release process . Th e diffusion release 
rate constant remained unchanged over a wide range of 
agitation speeds. Furthermore, by plotting the rate of 
release vs Q and 1/Q, linearity was obtained only with 1/Q 
(Figure 28). In addition to that, a plot of log Q vs log 
t (Figure 29), had a slope of 0.53. Thes~ findings are in 
marked contrast to those for film A and serve to confirm 
the diffusion-contro lled mechanism for film B. 
Clinical Pote ntial: 
The controlled release of drugs from dosage forms is 
a highly desirable attribute . Former studies (28) have show n 
that pure povidone films released their entire Cortisol con-
tent in only 30 minutes. On the other hand, pure l ano l in 
a lcohol films released less than 50% of their Cortisol con-
tent over a period of 24 hours. The films containing vary-
ing proportions of these two film formers showed drug r elease 
profiles somewhere between these two e xtremes. The lanolin 
alcohol-PVP film system offers promising potential in the 
design of a controlled or time drug delivery system. The 
physiological tolerance towards Povidone has made this poly-
mer very attractive for various applications in pharmacy a nd 
medicine. Although Cortisol was used as a model drug in this 
study, this delivery system could be adapted for other drugs 
as well. Although this work has emphasized topical applica-
tion, the film system studied here could be used in the design 
of dosage forms int e nded for the other routes as well. 
SUMMARY AND CONCLUSION 
In vitro release of Cortisol from pure lanolin alcohol 
and lanolin alcohol-PVP films was investigated. The effect 
of agitation was studied on both types of films while the 
effect of drug concentration and film thickness was studied 
on lanolin alcohol-PVP films. Solubility of the drug in 
the film matrix was det e rmined. The leaching of PVP from the 
film matrix and its effect on drug solubility in water was 
also studied. 
The r esults of the investigations on lanolin alcohol 
films showed that the rate of drug release from these films 
was not affected by the intensity of agitation. Furthermore, 
the film matrix remained intact throughout the r e l ease pro-
cess . Further anal ysis of the data r evealed that Higuchi's 
diffusion-controlled granular (since Cortisol is found to 
be insoluble in lanolin alcohol) matrix model explained the 
mechanism of Cortisol release from these films. 
The investigations of lanolin alcohol-PVP films have 
shown that although Higuchi's release rate constant was 
found to be independent of film thickness, it was affected 
by the intensity of agitation. In addition to that, PVP was 
found to diffuse out of the film matrix along with Cortisol. 
This explains the failure of this film system to conform 
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to the matrix-controlled diffusion model of Higuchi. The 
Cortisol rates show first-order dependence on drug concen-
tration. The first-order rate constant was found to be 
independent of drug concentration. Further analysis of the 
data confirmed this conclusion . 
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